HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Proposal for a new therapeutic strategy in high genital infections].

Abstract
78 cases of acute salpingitis were treated with the association Oflocet-Augmentin in a multicenter study. An accurate clinical and bacteriological evaluation was carried out prior to the treatment and a control laparoscopy was performed in 31 cases. A Chlamydia infection was responsible in 56 p. cent of the cases; only one bacteria was identified in 56 cases and an association of two or three bacteria in 15 cases; in 7 cases, no bacteria was identified. The antibiotic association was effective in 96 p. cent of the cases, with a good clinical and biological tolerance. Three failure were reported: one in an infection secondary to a non identified bacteria, and two in Chlamydia infections where, despite the clinical cure, a positive culture persisted in the abdomen. The association Oflocet-Augmentation is therefore recommended in the treatment of high genital infections.
AuthorsP Verhoest, J Orfila, F Haider, M Vitse, J C Boulanger
JournalRevue francaise de gynecologie et d'obstetrique (Rev Fr Gynecol Obstet) Vol. 84 Issue 12 Pg. 933-40 (Dec 1989) ISSN: 0035-290X [Print] France
Vernacular TitleProposition d'une nouvelle stratégie thérapeutique dans les infections génitales hautes.
PMID2696066 (Publication Type: Clinical Trial, English Abstract, Journal Article, Multicenter Study)
Chemical References
  • Clavulanic Acids
  • Amoxicillin-Potassium Clavulanate Combination
  • Amoxicillin
  • Ofloxacin
Topics
  • Adolescent
  • Adult
  • Amoxicillin (administration & dosage, therapeutic use)
  • Amoxicillin-Potassium Clavulanate Combination
  • Chlamydia Infections (drug therapy, microbiology, physiopathology)
  • Clavulanic Acids (administration & dosage, therapeutic use)
  • Drug Therapy, Combination (administration & dosage, therapeutic use)
  • Female
  • Humans
  • Microbial Sensitivity Tests
  • Middle Aged
  • Multicenter Studies as Topic
  • Ofloxacin (administration & dosage, therapeutic use)
  • Salpingitis (drug therapy, microbiology, physiopathology)
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: